company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62138000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62138000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11076000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51062000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17649000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18602000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14811000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,376000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,380000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15191000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5757000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9434000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9434000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-374000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9808000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31097445.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 10:47:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73986000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73986000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11532000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11532000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62454000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20693000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21156000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41849000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20605000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1003000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-965000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19640000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7696000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11944000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11944000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1176000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13120000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31301796.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32113313.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 18:14:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18533000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18533000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1068000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1068000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17465000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18212000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34759000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52971000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35506000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35472000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12299000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23173000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23173000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1776000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21397000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35179317.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35179317.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 11:29:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88141000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88141000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16069000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16069000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72072000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20384000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31481000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51865000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20207000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20186000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7663000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12523000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12523000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1687000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14210000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35619514.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36667452.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 18:11:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58762000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58762000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10706000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10706000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48056000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17432000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29216000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46648000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1408000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,37000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1467000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1604000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-137000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-137000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1686000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1549000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35855217.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36447933.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 14:53:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,107948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,107948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14328000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14328000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18254000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29376000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47630000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45990000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-6000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-258000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-228000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45762000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18862000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1757000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28657000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35658907.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36206052.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50311000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50311000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7511000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7511000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19492000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26246000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,9600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55338000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12538000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,854000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,876000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11662000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3640000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8022000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1193000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6829000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36045839.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36045839.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 17:49:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,70379000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,70379000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13186000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13186000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57193000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17895000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30645000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48540000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8653000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,907000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,936000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9589000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4043000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5546000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5546000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2086000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7632000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36182826.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36556697.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 18:43:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66592000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66592000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10230000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10230000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56362000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19155000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27390000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46545000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9817000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9856000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5620000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6617000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36202801.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36670094.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:55:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94606000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94606000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15150000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15150000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79456000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19476000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35945000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55421000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24035000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,225000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,247000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24282000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9283000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14999000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14999000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1105000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16104000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36080495.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36420662.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5698000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5698000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37402000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20028000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30724000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50752000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13350000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13321000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4516000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-743000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8062000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35968064.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35968064.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 15:20:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,82436000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,82436000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16945000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16945000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20501000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30278000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50779000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14712000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14737000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4381000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10356000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10356000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-128000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10484000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36144063.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36527014.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 18:48:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89102000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89102000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20063000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20063000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69039000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21955000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28937000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50892000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18147000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,58000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,146000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18293000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4802000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13491000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36272579.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37015529.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.36
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 15:23:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,98107000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,98107000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19421000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19421000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78686000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25399000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29994000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55393000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,23293000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-14000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,333000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,365000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23658000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8441000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15217000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15217000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15222000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36201283.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36747556.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53884000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53884000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18997000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34887000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30089000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30256000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60345000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25458000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3535000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,512000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2983000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28441000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8205000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20236000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36854370.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36854370.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 18:43:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,110325000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,110325000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34507000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34507000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75818000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30555000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37401000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67956000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7862000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1721000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1322000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-368000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7494000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2465000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5029000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5029000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5029000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37416554.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38333425.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:39:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137954000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137954000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32423000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32423000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105531000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30292000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44207000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74499000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31032000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1810000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,420000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1331000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29701000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7869000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21832000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21832000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21832000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37507220.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46557163.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:16:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102303000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102303000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16036000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16036000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,86267000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17658000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-7143000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10515000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,75752000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1174000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,190000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,672000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-312000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,75440000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27799000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47641000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-17525000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30116000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30116000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37344891.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45802807.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63633000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63633000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18748000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18748000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44885000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34493000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38702000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73195000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28310000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1661000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1479000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29789000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8269000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21520000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21520000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21520000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37949358.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37949358.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126112000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126112000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27266000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27266000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98846000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36453000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40941000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77394000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21452000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1628000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,273000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-497000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1852000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38480754.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47410413.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:28:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,158378000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,158378000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35240000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35240000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123138000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34179000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59979000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63159000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1635000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,104000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,519000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1012000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62147000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20059000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42088000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-5145000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36943000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36943000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38831341.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47784550.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 17:39:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,141208000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,141208000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26232000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26232000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,114976000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24399000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5364000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29763000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,85213000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1599000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1455000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83758000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27010000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56748000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-23401000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33347000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38595435.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47255842.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102964000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102964000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24001000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24001000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78963000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31713000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26093000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57806000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21157000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1524000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,186000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1303000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19854000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7965000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11889000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-7898000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3991000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3991000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39542656.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48359892.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 18:09:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,91241000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,91241000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29465000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29465000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61776000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35925000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27893000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63818000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2042000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1510000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,219000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1267000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3309000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1267000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2042000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-8905000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10947000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10947000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40202821.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40202821.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:46:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,142914000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,142914000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39560000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39560000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103354000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40688000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27188000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67876000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35478000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2049000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,358000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-234000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1925000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33553000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13165000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20388000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,952000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21340000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40465423.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49440313.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q3,2016-07-01,2016-09-30,2017-11-03 12:25:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,151681000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,151681000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33274000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33274000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118407000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34774000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25726000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50907000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2517000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-763000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1475000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49102000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16837000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32265000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5151000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37416000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37416000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,116858000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,116858000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46322000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46322000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70536000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35150000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20476000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55626000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14910000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1938000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,373000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1265000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13645000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3160000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10485000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10485000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10485000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40727755.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49718426.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:04:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100772000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100772000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34624000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34624000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66148000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31868000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25751000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57619000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8529000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1805000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,583000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-586000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1808000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6721000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2105000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4616000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4616000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4616000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41013764.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50078594.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 17:55:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,149434000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,149434000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44503000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44503000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104931000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34503000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22659000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57162000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47769000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1991000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,637000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-101000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1455000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46314000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12763000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33551000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33551000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33551000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41222504.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50467829.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 18:06:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,193836000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,193836000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,62251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,62251000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,131585000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41379000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28514000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78493000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53092000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,866000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1593000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1287000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1172000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51920000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17972000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33948000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.8
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.8
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49580089.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49580089.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:05:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,220200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,220200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,85300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,85300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,66800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.98
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 18:24:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,173600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,173600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 18:02:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,270800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,270800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,13300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,190600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,190600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,14500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,126000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 18:16:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,100800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,100800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,142400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,63900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,14700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,149400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 18:24:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,311800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,311800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,108000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,108000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,14700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,133100000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15700000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 18:02:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,360400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,360400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,132900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,132900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72300000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,14800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,149900000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,77600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9000000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6200000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,71400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24600000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46800000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51500000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51400000.0
Emergent BioSolutions Inc,EBS,549300YW6TUOX8BE5103,0001367644,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
